OPRX ▼ -0.1% - OptimizeRx Corporation $OPRX - OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor OptimizeRx appointed Troy Sarich, a pharma commercialization and AI expert, as a company advisor, but the stock moved only marginally lower, declining 0.1% today. The modest reaction suggests investors are taking a wait-and-see approach to how this advisory role will contribute to the company's growth strategy. 02-SEP-2026 07:30 AM ET